Belvedere Trading LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 2 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 13.0%.

Quarter-by-quarter ownership
Belvedere Trading LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$128,028
-30.2%
15,388
-15.9%
0.00%
Q1 2023$183,549
+11.7%
18,300
-51.3%
0.00%
Q4 2022$164,312
-43.9%
37,600
-20.2%
0.00%
-100.0%
Q2 2022$293,000
+110.8%
47,100
+166.1%
0.01%
+125.0%
Q1 2022$139,000
-71.7%
17,700
-74.2%
0.00%
-81.8%
Q4 2021$491,000
+358.9%
68,600
+404.1%
0.02%
+633.3%
Q3 2021$107,00013,6080.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 136,593$1,106,0000.35%
Total Clarity Wealth Management, Inc. 11,425$93,0000.04%
Virtu Financial LLC 32,952$267,0000.02%
Apollon Wealth Management, LLC 19,400$157,0000.02%
Summit Trail Advisors, LLC 35,000$284,0000.02%
FNY Investment Advisers, LLC 4,687$37,0000.02%
Freedom Investment Management, Inc. 16,649$135,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 156,946$1,271,0000.01%
Belvedere Trading LLC 13,608$107,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 10,000$81,0000.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders